期刊文献+

数值化便潜血试验在大肠疾病诊断中的应用 被引量:2

The evaluation of the quantitative immunochemical fecal occult blood test in the diagnosis of colorectal diseases
下载PDF
导出
摘要 目的探讨数值化便潜血试验在不同大肠疾病中的临床诊断价值。方法对在我院内镜中心同时接受胃镜和结肠镜检查的患者在检查前留其大便标本后使用数值化法和免疫胶体金法进行检查。结果共检测标本237例,同时进行了两种试验方法的配对标本136例,数值化法在结直肠癌中的阳性率明显高于免疫胶体金法,分别为91.2%和55.9%,差异有统计学意义(P<0.01);在炎症性肠病分别为87.5%和62.5%,大肠息肉9.1%和4.5%,正常大肠2%和6%,阳性率均无显著差异(P>0.05)。结论与免疫胶体金法相比,数值化便潜血试验对结直肠癌有更高的诊断价值。 Objective To investigate the clinical value of the quantitative immunochemical fecal occult blood test(FOBT) in different colorectal diseases.Methods Patients who were going to undergo gastroscopy and colonoscopy simultaneously accepted the quantitative immunochemical FOBT and the colloidal gold immunochemical FOBT.Results The number of total sample was 136.The positive rates of the quantitative immunochemical FOBT and the colloidal gold immunochemical FOBT in colorectal cancer were 91.2% and 55.9%,inflammatory bowel disease were 87.5% and 62.5%,colorectal polyp were 9.1% and 4.5%,and normal group(normal appearance of colorectal mucosa) were 2% and 6%,respectively.The positive rate of the quantitative immunochemical FOBT in colorectal cancer was significantly higher than that of the colloidal gold immunochemical FOBT(P0.01),while no statistical difference was found in the other diseases(P0.05).Conclusion Compared with the colloidal gold immunochemical FOBT,the quantitative immunochemical FOBT has more sensibility in the diagnosis of colorectal cancer.
出处 《胃肠病学和肝病学杂志》 CAS 2010年第5期397-398,共2页 Chinese Journal of Gastroenterology and Hepatology
关键词 免疫胶体金法便潜血试验 数值化便潜血试验 结直肠癌 Colloidal gold immunochemical fecal occult blood test Quantitative immunochemical fecal occult blood test Colorectal cancer
  • 相关文献

参考文献6

二级参考文献42

  • 1吴元健,徐卫东,陈昭华,赵星.iQ^(TM) 200全自动尿沉渣定量分析仪的临床应用与评价[J].检验医学,2005,20(4):392-394. 被引量:16
  • 2杨海芸,戈之铮.粪便隐血试验在结直肠癌早期筛查中的研究现状[J].胃肠病学,2006,11(6):376-378. 被引量:8
  • 3Lowenfels AB. Fecal occult blood testing as a screening procedure for colorectal cancer. Ann Oncol, 2002,13:40-43
  • 4Strul H, Arber N. Fecal occult blood test for colorectal cancerscreening. Ann Oncol,2002,13:51-56.
  • 5Bleiberg H. Hemoccult should no longer be used for the screening of colorectal cancer. Ann Oncol, 2002,13:44-46.
  • 6Autier P. Should organised faecal occult blood test screening be established? Ann Oncol, 2002,13:57-60.
  • 7Honda K. Factors associated with colorectal cancer screening among the US urban Japanese population. Am J Public Health, 2004,94:815-822.
  • 8Young GP, Rozen P. Fecal immunochemical tests(FITs) for hemoglobin :a paradigm shift in noninvasive fecal screening tests for colorectal cancer. [ J/OL ]. [ 2007-07-10 ]. http://omge. galayaa. coM/publications/archive/2006_1/sci/sci6. htm.
  • 9Wong WM,Lam SK,Cheung KL,et al. Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population. Cancer, 2003,97 : 2420- 2424.
  • 10Levi Z, Hazazi R, Rozen P, et al. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test. Aliment Pharmacol Ther, 2006,23 : 1359-1364.

共引文献35

同被引文献28

  • 1刘香,郑长青.炎症性肠病慢性腹泻的药物治疗[J].实用药物与临床,2005,8(6):7-9. 被引量:5
  • 2王志红,靳淑玲,王北宁.全自动免疫化学分析仪定量检测便隐血的方法学研究[J].科学技术与工程,2006,6(19):3173-3175. 被引量:3
  • 3Young G P, St John D J, Winawer S J, et al. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol,2002,97 (10) :2499-2507.
  • 4Liebeman D A, Weiss D G; Veterans Affairs Cooperative Study Group 380. One -time screening for colrectal cancer with combined fecal occult blood testing and examination of the distal colon. N Engl J Med, 2001,345(8):555-560.
  • 5Scales C D Jr, Fein S, Muir A J, et al. Clinical utilization of digital rectal examination and fecal occult blood upon hospital admission. J Clin Gastroentero1,2006,40 (10) :913-918.
  • 6MOOIWEER E,SEVERS M,SCHIPPER ME,et al.Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients:a plea for deep remission[J].J Crohns Colitis,2015,9(1):50-55.
  • 7LAZEBNIK LBi GUSE N-ZADE MG,EFREMOV LI,et al.Fe- cal calprotectin as a biomarker effectiveness of various interven- tions in patients with inflammatory bowel disease[J].Eksp Klin Gastroenterol,2013,(8):11-16.
  • 8MORTENSEN JH,GODSKESEN LE,JENSEN MD,et al.Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type IQ Collagen Are Novel Serological Biomark- ers to Differentiate Crohn's Disease from Ulcerative Colitis[J].J Crohns Colitis,2015,9(10):863-872.
  • 9MARCHESI JR,HOLMES E,KHAN F,et al.Rapid and non- invasive metabonomic characterization of inflammatory bowel dis- ease[J].J Proteome Res,2007,6(2):546-551.
  • 10VERNIA P,GNAEDINGER A,HAUCK W,et al.Organic an- ions and the diarrhea of inflammatory bowel disease[J].Dig Dis Sci,1988,33(11):1353-1358.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部